MLI Certified

On-Demand Activities

Search
Generic filters
Credit Amount (at least)
Course Types
Learner Specialties
Therapeutics Areas
Genomics and Hematologic Malignancies: Beyond the Philadelphia Chromosome
It has been 60 years since the discovery of a chromosomal abnormality in CML; the so-called Philadelphia chromosome. Since then genomics has revolutionized cancer care and the impact in hematologic malignancies is plentiful. Healthcare providers must understand the science to be able to apply in practice and communicate complex information to patients and caregivers. This session will provide an overview of foundational genomic concepts and how genomics is applied across the care continuum for hematologic cancers. Case studies examining the application of testing to “real life” situations will be presented and resources for patients will be shared.
A Personalized Approach to Guide Risk-Adapted Treatment Decisions in Myelofibrosis: Applying the Latest Clinical Evidence on JAK Inhibitors and Novel Combination Therapies to Improve Patient Outcomes
In this activity, hematology-oncology experts discuss the current and emerging therapeutic options for the management of patients with myelofibrosis.
Breakthroughs in Spinal Muscular Atrophy: Managing the Life-Changing Impact of Gene Replacement Therapy
In this activity, a neurologist discusses the life-changing impact of gene replacement therapy in spinal muscular atrophy.
Conversations on the New Wave of Innovative Therapy in Follicular Lymphoma: Implications for Personalized Medicine
In this activity, two lymphoma experts discuss the newest treatment options for follicular lymphoma (FL). Hear what Drs. John Pagel and Ian Flinn have to say about recent evidence supporting a personalized approach to treating patients with relapsed FL, including the integration and use of novel targeted options, such as PI3K and EZH2 inhibitors. The experts also provide their insights on baseline factors that can help identify patients who may benefit from the use of such innovative agents, as well as safety management.
Modern Management of ITP: Thinking Beyond the Conventional Therapies
In this animated, visually-enhanced activity, an expert in hematology-oncology discusses current standards for diagnosing and treating idiopathic thrombocytopenic purpura—and provides an update on the challenges associated with modern care and the promise of novel therapeutic options for disease management.
A New Era of Migraine Management: Recent Updates on Recognition, Acute Treatment and Prevention for Emergency Physicians
In this activity, an expert in emergency medicine discusses the diagnosis and management of patients with migraine in the emergency department setting.
A New Treatment Era for Light-Chain Amyloidosis:Interprofessional Lessons From a Center of Excellence
In this activity, a panel of experts discusses a team-based approach to the management of light chain (AL) amyloidosis. Hear from Suzanne Lentzsch, MD, PhD, Mathew S. Maurer, MD, and Margaret Cuomo, MSN, FNP-C, from the Columbia University Medical Center, as they give insights on diagnostic strategies for AL amyloidosis and as they explore treatment guidelines, evidence, and safety concerns of established and novel approaches to managing AL amyloidosis.
Integrating the Latest Evidence into Practice: Expert Insights on Targeted Biologic Therapy for Pediatric and Adult Patients with Moderate to Severe Atopic Dermatitis
In this activity, an expert dermatologist discusses the latest evidence from the 30th European Academy of Dermatology and Venereology Congress for current and emerging targeted biologic therapies for moderate to severe atopic dermatitis in adults and children.
The Evolving Role of Oxybate Agents in the Management of Narcolepsy: A Visual Exploration of Individualized Care
In this infographic-based activity, an expert in sleep medicine discusses the signs and symptoms of narcolepsy and shares evidence-based approaches to individualizing care.
Visualizing Progress for TP53 Mutant AML: A Pathology-Guided Journey through Diagnostic Principles and Modern Treatment
In this activity, an expert pathologist discusses the prognostic relevance of TP53 mutations, current diagnostic tools and principles for capturing TP53-mutated acute myeloid leukemia (AML), and new developments with innovative therapy for TP53-mutated AML.
On the Cusp of a New Era in Treatment for Eosinophilic Esophagitits: Expert Insights on the Latest Advances in Targeted Therapy
In this activity, an expert in eosinophilic esophagitis discusses the latest research, data, and guidelines on novel and emerging targeted therapies.
Overcoming the Challenges of Diverse TGCT Presentations: Diagnostic and Treatment Principles for the Multidisciplinary Team
Despite the widespread use of surgery as a standard of care for tenosynovial giant cell tumor (TGCT), several therapeutic challenges remain, particularly in the setting of diffuse TGCT, where recurrent and difficult-to-treat disease can be present. In this activity, an orthopedic surgeon and medical oncologist debate the case-based management of challenging TGCT presentations, and illustrate the nuances of multidisciplinary collaboration when managing patients with TGCT. Throughout, the panelists profile a modern management synthesis that combines surgery, physical therapy, and the use of targeted agents, including for patients for whom surgery alone is unlikely to be beneficial.
Episode 2 of 2 | The Heroes Among Us - Collaborating with Patients to Control Glucose and Decrease Weight
Social determinants of health and providers’ unconscious bias can contribute to myriad unmet needs in patients struggling with the twin epidemics of T2D and obesity. Treat someone’s glucose and you treat their diabetes. But treat someone’s obesity, and you treat the whole person. In The Heroes Among Us: Collaborating with Patients to Control Glucose and Decrease Weight, episode 2 of the Med Table Talk series, certified diabetes care and education specialists address these issues head-on. They then provide strategies for improved shared decision making and tips for effective conversations about weight management.
Upstream and Downstream Targeting of the Complement Pathway to Manage PNH: Current and Emerging Inhibitors
In this activity, an expert in hematology-oncology provides an overview of paroxysmal nocturnal hemoglobinuria (PNH) and discusses current and emerging treatment options for managing PNH
Interprofessional Perspectives on Safety Management With Targeted Therapy for B-cell Malignancies
In this activity, a hematologist-oncologist, cardiologist, oncology nurse, and pharmacist team up to discuss targeted agents (including BTK and BCL-2 inhibitors) in B-cell malignancies and how the team works closely together to manage toxicity and safety concerns associated with targeted therapies. Case scenarios are presented to illustrate how a collaborative approach is not only necessary for managing patients with B-cell cancers, such as CLL and MCL, but can also improve patient outcomes through monitoring and managing adverse events.
Demystifying the Role of Incretin-Based Weight Loss Pharmacotherapy: A Patient-Centered Approach to Overcoming Barriers and Addressing Underlying Causes of Obesity
In this animated activity, an expert in obesity reviews current evidence for incretin-based weight-loss pharmacotherapy and offers evidence-based approaches to individualizing care for patients with obesity.
Beyond TNF Inhibitors: Latest and Emerging Evidence on Novel Cytokine-Modulating Strategies in the Treatment of Moderate to Severe Psoriasis
In this activity, an expert in dermatology discusses the latest evidence on novel cytokine-modulating strategies in the treatment of moderate to severe psoriasis.
Across the Age Spectrum: Expert Insights on Emerging Uses of Targeted Therapy for the Treatment of Uncontrolled Moderate-to-Severe Asthma
In this activity, an expert in pulmonology discusses the latest clinical research and treatment guidelines on approved biologic therapies for the management of adult and pediatric patients with uncontrolled moderate to severe asthma.
Episode 4 of 4 of the series on: The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes
Opening the CAR(T) Door to Get Patient to Therapy, episode 4 of the 4-part educational initiative The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes, is designed for community-based oncology clinicians. This CE activity includes conversations among CAR-T experts and a community clinician; it includes patient video clips and numerous downloadable resources including a directory of CAR-T treatment centers organized by state. This activity focuses on managing logistics associated with CAR-T therapy, including common misperceptions, the numerous services offered by treating centers, and how to overcome roadblocks for your patients.
New Insights How Does Real-World Evidence Influence VTE Management? A Visual Exploration of Real-World Studies of DOACs
In this activity, a vascular medicine expert discusses real-world evidence (RWE) for treating patients with or at risk for venous thromboembolism (VTE) with direct oral anticoagulants (DOACs).
Leading the Way to Optimal Care in Multiple Myeloma: Nurse Perspectives on the Practicalities and Potential of Novel Therapeutics
In this activity, a nurse expert discusses novel therapeutics in multiple myeloma and the important role nurses play in the treatment of this disease.
Envisioning the Future of Emerging Nonfactor Therapies in Hemophilia A and B: The Art and Science of RNA Interference
In this activity, an expert in hemophilia explores the evidence supporting novel, emerging hemophilia therapeutics and provides guidance on the implications of the evidence presented for real-world practice.
Taking it From the Top: Targeting a New Approach to Control Severe Asthma
In this activity, experts in asthma detail the pathophysiology of severe asthma, with a discussion of the underlying mechanisms behind both type 2 and non–type 2 asthma, and novel and emerging therapies for its treatment.
Taking the Fight to AML: Oncology Nurse Perspectives, Principles, and Practice in an Era of Innovative Therapies
In this activity, two expert nurse panelists use case-based teaching to illustrate solutions to clinical challenges associated with nursing care in the modern acute myeloid leukemia (AML) treatment landscape in which innovative therapies (including targeted agents, newer cytotoxics, and epigenetic approaches) are now core patient treatment strategies.
Scroll to Top